Medicine
Acetazolamide 125 mg tablet
Acetazolamide 125 mg tablet is a generic prescription medicine for oral use, made by 22 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F).
Key facts
- Active ingredient (INN)
- Acetazolamide
- Brand
- Sold under the generic name
- Strength
- 125 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 120 tablets and 31 more
- Manufacturers
- Avet PharmaceuticalsIndiaZydus LifesciencesIndiaAjanta PharmaIndiaAurobindo PharmaIndiaLifestar PharmaIndiaStrides PharmaIndiaViona PharmaceuticalsIndiaPD-Rx PharmaceuticalsProficient RxA-S Medication Solutions
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- S01EC01 Acetazolamide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 October 2016
- Identifiers
- RxCUI 197303, 197304DailyMed set ID c525ef20-ec9a-4ffd-b5ea-e53c186fe716, f7227cc5-0a80-47df-baf8-09f1b22b187e, 278878bc-da9c-09d4-e063-6394a90abaf7 +23NDC 72789-238, 63629-1194, 68071-3728 +23Application ANDA211556, ANDA214282, ANDA209734 +8
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 70710-1238-1 | Zydus LifesciencesIndia | 4 August 2023 |
| 100 tablet in 1 bottle | 70771-1827-1 | Zydus LifesciencesIndia | 15 July 2023 |
| 100 tablet in 1 bottle | 27241-132-04 | Ajanta PharmaIndia | 11 September 2023 |
| 100 tablet in 1 bottle | 59651-905-01 | Aurobindo PharmaIndia | 30 May 2025 |
| 100 tablet in 1 bottle | 23155-287-01 | Avet PharmaceuticalsIndia | 27 October 2016 |
| 1000 tablet in 1 bottle | 23155-287-10 | Avet PharmaceuticalsIndia | 27 October 2016 |
| 100 tablet in 1 bottle | 70756-720-11 | Lifestar PharmaIndia | 13 November 2020 |
| 100 tablet in 1 bottle | 64380-833-06 | Strides PharmaIndia | 20 November 2017 |
| 100 tablet in 1 bottle | 72578-149-01 | Viona PharmaceuticalsIndia | 15 July 2023 |
| 100 tablet in 1 bottle | 81005-104-01 | Aarkish Pharmaceuticals NJ | 3 December 2024 |
| 1000 tablet in 1 bottle | 81005-104-10 | Aarkish Pharmaceuticals NJ | 3 December 2024 |
| 100 tablet in 1 bottle | 72888-047-01 | Advagen Pharma | 19 August 2021 |
| 1000 tablet in 1 bottle | 70954-033-20 | ANI Pharmaceuticals | 17 October 2019 |
| 100 tablet in 1 bottle | 70954-033-30 | ANI Pharmaceuticals | 17 October 2019 |
| 120 tablet in 1 bottle | 62135-607-12 | Chartwell RX | 9 May 2023 |
| 100 tablet in 1 bottle | 71930-008-12 | Eywa Pharma | 30 January 2020 |
| 1000 tablet in 1 bottle, plastic | 52817-200-00 | Trupharma | 1 June 2021 |
| 100 tablet in 1 bottle, plastic | 52817-200-10 | Trupharma | 1 June 2021 |
| 100 tablet in 1 bottle | 63629-1194-1 | Bryant Ranch Prepack | 29 October 2024 |
| 100 tablet in 1 bottle | 72162-1978-1 | Bryant Ranch Prepack | 23 March 2026 |
| 12 tablet in 1 bottle | 68071-3550-1 | NuCare Pharmaceuticals,Inc | 1 December 2023 |
| 100 tablet in 1 bottle | 68071-3632-1 | NuCare Pharmaceuticals,Inc | 18 June 2024 |
| 6 tablet in 1 bottle, plastic | 72789-045-06 | PD-Rx Pharmaceuticals | 4 January 2021 |
| 12 tablet in 1 bottle, plastic | 72789-045-12 | PD-Rx Pharmaceuticals | 6 January 2021 |
| 100 tablet in 1 bottle, plastic | 72789-238-01 | PD-Rx Pharmaceuticals | 10 March 2022 |
| 100 tablet in 1 bottle | 50090-5617-0 | A-S Medication Solutions | 23 August 2021 |
| 12 tablet in 1 bottle | 50090-5617-1 | A-S Medication Solutions | 23 August 2021 |
| 100 tablet in 1 bottle | 42291-089-01 | AvKARE | 18 May 2017 |
| 100 tablet in 1 bottle | 10135-830-01 | Marlex Pharmaceuticals | 1 February 2026 |
| 30 tablet in 1 bottle, plastic | 51655-331-52 | Northwind Health | 28 March 2023 |
| 12 tablet in 1 bottle | 68071-3728-1 | NuCare Pharmaceuticlas | 22 November 2024 |
| 30 tablet in 1 bottle | 71205-308-30 | Proficient Rx | 1 September 2019 |
| 60 tablet in 1 bottle | 71205-308-60 | Proficient Rx | 1 September 2019 |
| 90 tablet in 1 bottle | 71205-308-90 | Proficient Rx | 1 September 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 27 July 1953 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Acetazolamide
Clinical summary
Acetazolamide is a carbonic anhydrase inhibitor indicated for the prevention or amelioration of symptoms associated with acute mountain sickness in climbers attempting rapid ascent and in those, among other approved uses. MedsAcross supplies Acetazolamide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AcetazolamideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Acetazolamide prescribing information (Lifestar Pharma) · U.S. National Library of Medicine, DailyMed
Need Acetazolamide 125 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.